Fundraising FoxZ-Alpha Therapeutics
1 known investors
Find your way into Z-Alpha Therapeutics
Sign up to see every warm intro you have to Z-Alpha Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Z-Alpha Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Z-Alpha is a biotech developing targeted alpha-emitting radiotherapeutics based on a proprietary astatine-211 (211At) platform, including isotope supply, labeling/linker technologies, and a pipeline of therapeutic programs. It targets high unmet medical needs across multiple large-market oncology indications.
Investors · 1
Frequently asked questions
- What does Z-Alpha Therapeutics do?
- Z-Alpha is a biotech developing targeted alpha-emitting radiotherapeutics based on a proprietary astatine-211 (211At) platform, including isotope supply, labeling/linker technologies, and a pipeline of therapeutic programs. It targets high unmet medical needs across multiple large-market oncology indications.
- Who are Z-Alpha Therapeutics's investors?
- Z-Alpha Therapeutics's investors include Viking Global.